Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
The Native Antigen Company Expands Range of Norovirus-Like Particles
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of […]
First-To-Market SyntraNet™ and Martti™ Integration Brings Whole-Person Care in 250 Languages to 2,100 Health Systems and Health Plans
UpHealth, Inc. (NYSE: UPH) today announced a comprehensive integration of its technology platforms that expands the […]
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp’s OmniSeq to […]
Gracell Biotechnologies Unveils Innovation Center in U.S.
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell” or the “Company”), a global clinical-stage biopharmaceutical company dedicated […]
Arcensus has Appointed Prof. Dr. Arndt Rolfs as New CEO
Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of […]
Roche Launches the Cobas® Pulse System, an Industry First Professional Blood Glucose Management Solution with Mobile Digital Health Capabilities to Improve Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in […]
Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer
Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]
Robocath Concludes First European Clinical Study to Demonstrate Safety and Efficacy of Robotic Coronary Angioplasty Performed with R-One
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more